NEW YORK – Oct. 3, 2023 – Five attorneys from global law firm Greenberg Traurig, LLP are recognized in the 2023 edition of the Intellectual Asset Management (IAM) Strategy 300: The World’s Leading IP Strategists.
According to the publication, the IAM Strategy 300 identifies individuals “leading the way in the development and implementation of strategies that maximize the value of IP portfolios.” The guide lists individuals from various entities, including service providers, corporations, research institutions, and universities. Honorees are identified through confidential online nominations and extensive research involving interviews and email exchanges with senior members of the global intellectual property (IP) community.
The following shareholders were selected:
- James J. DeCarlo is actively involved in virtually all aspects of strategic IP counseling and focuses on litigating, licensing, and procuring patents in the software, hardware, internet, networking, ML/AI and VR/AR spaces, among many others, for domestic and foreign clients, from early-stage companies to multinationals.
- David J. Dykeman, co-managing shareholder of Greenberg Traurig’s Boston office and co-chair of the firm's global Life Sciences & Medical Technology Group, focuses on securing worldwide IP protection and related business strategy for high-tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology.
- Roman Fayerberg works with clients, ranging from startups to global companies, to strategically protect and leverage their innovations globally in a variety of technical areas, with a particular focus on medical devices, robotics, diagnostic, and imaging systems.
- Chinh H. Pham, co-chair of the Venture Capital and Emerging Technology Practice, is a registered patent attorney focusing on business strategy and the strategic creation, implementation, and protection of IP rights for public companies as well as startups in the areas of software, materials, medical devices, and life sciences.
- Andrew B. Schwaab provides strategic advice regarding IP and associated business matters, including counseling on cross-border IP issues, global patent portfolio management, patent litigation, licensing, SEP/FRAND disputes, due diligence, patent monetization, and validity, infringement, and freedom-to-operate issues.